SEC Tracker
Get the app
PFE · XBRL financial data

Pfizer financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (PFE's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 29, 2024Dec 31, 2024Mar 30, 2025Jun 29, 2025Sep 28, 2025Dec 31, 2025Mar 29, 2026Jun 28, 2026Sep 27, 2026
Revenue14,249*14,87913,28317,70217,763*13,71514,65316,65417,557*14,45115,03416,583
Revenue from contracts with customersyear only———————————
Cost of goods and services sold7,563*3,3793,3005,2635,909*2,8453,7784,1725,272*3,5484,0924,028
Selling, general and administrative4,575*3,4953,7173,2444,274*3,0313,4153,1864,162*2,9613,4113,279
Interest income609*129130116171*143156138166*115113108
Interest expense688*790778783739*654654652711*668667662
Other income (expense)479*(680)(1,107)(243)(2,358)*(953)(739)(517)(4,514)*(861)(3,716)(288)
Income tax expense (benefit)(795)*293(134)234(421)*(189)141(216)(2)*461(407)134
Net income (loss)(3,369)*3,115414,465410*2,9672,9103,541(1,648)*2,687(248)3,242
Earnings per share, basic USD per share(0.60)*0.550.010.790.07*0.520.510.62(0.29)*0.47(0.04)0.57
Earnings per share, diluted USD per share(0.59)*0.550.010.780.07*0.520.510.62(0.29)*0.47(0.04)0.56
Weighted average shares, basic millions of shares5,646*5,6575,6665,6675,666*5,6755,6855,6855,687*5,6915,6995,700
Weighted average shares, diluted millions of shares5,750*5,6975,6965,7055,702*5,7105,7065,7145,722*5,7315,6995,751

Balance sheet

CSV

Fiscal quarters (PFE's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 29, 2024Dec 31, 2024Mar 30, 2025Jun 29, 2025Sep 28, 2025Dec 31, 2025Mar 29, 2026Jun 28, 2026Sep 27, 2026
Cash and cash equivalents2,8537191,0521,0921,0431,4301,6381,3431,1421,7039761,824
Marketable securities4,4008,2174,4016,84910,88113,9529,52510,1239,1838,1897,2819,118
Marketable securities, non-current1501376960—111000
Accounts receivable11,17710,98911,39314,45111,46311,84512,07814,26011,87412,58512,49014,192
Inventory10,18910,89211,44711,72110,85110,85211,66911,46810,65410,6679,94510,022
Total current assets43,33342,41537,82543,22350,35845,86143,70346,92442,89842,82241,35845,009
Property and equipment, net18,94018,80318,95718,54118,39318,34718,77618,88019,31719,40219,02919,048
Right-of-use asset2,924———2,289———2,213———
Goodwill67,78369,29768,44568,57068,52768,44468,99769,10171,26471,40971,41971,464
Total assets226,501221,095216,193219,476213,396208,028206,095208,731208,160207,618201,131204,544
Accounts payable6,7105,5915,1065,3145,6335,2405,1665,0245,2404,5064,5814,070
Commercial paper7,9656,9337,9645,8412,453155000———
Current portion of long-term debt2,2541,0013,7453,7463,7473,7494,2464,2472,9973,8612,6052,604
Total current liabilities47,79440,49743,81943,21142,99536,45237,72636,59636,98434,34832,64631,726
Long-term debt61,53861,30757,50658,00257,40557,63957,50257,40961,64160,56560,49559,997
Lease liability, non-current2,626———2,286———2,291———
Total liabilities137,213128,537128,218126,918124,899117,391117,083115,635121,385117,214115,639115,243
Retained earnings118,353121,318116,596121,059116,725119,590117,609121,150114,610117,238112,087115,328
Total stockholders' equity89,01492,28287,70092,28688,20390,33888,69592,80186,47690,10185,19089,001
Total liabilities and equity226,501221,095216,193219,476213,396208,028206,095208,731208,160207,618201,131204,544
Common shares outstanding (cover page) millions of shares5,6475,6675,6675,6675,6675,6855,6865,6865,6865,6995,7005,700

Cash flows

CSV

Fiscal quarters (PFE's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 29, 2024Dec 31, 2024Mar 30, 2025Jun 29, 2025Sep 28, 2025Dec 31, 2025Mar 29, 2026Jun 28, 2026Sep 27, 2026
Net income (loss)(3,369)*3,115414,465410*2,9672,9103,541(1,648)*2,687(248)3,242
Stock-based compensation121*220206*274*177*170203*201*225*272249*362*
Depreciation and amortization1,670*1,7361,7301,7551,791*1,6181,6251,6621,687*1,6131,6221,577
Net cash from operating activities5,240*1,090(1,781)*6,714*6,721*2,335(582)*4,603*5,348*2,615835*5,375*
Purchases of property and equipment1,044*704637*651*917*564618*602*845*436533*573*
Net cash from investing activities(10,996)*1,7324,600*(2,057)*(1,623)*3,2743,951*(2,430)*(6,146)*7852,106*(2,026)*
Share repurchases0*———year only———————
Proceeds from long-term debt0*——0*0*——0*5,991*——0*
Repayments of long-term debt0*1,2501,000*0*0*03,750*0*3,007*——0*
Net cash from financing activities5,442*(4,931)(2,459)*(4,636)*(5,114)*(5,227)(3,196)*(2,477)*596*(2,856)(3,663)*(2,506)*
Net change in cash(316)*(2,137)343*29*(45)*375213*(301)*(196)*563(727)*845*

Compare with peers

The peer list for this company is being put together from its industry's latest filings. Reload the page in a minute to see it.

Not investment advice. Not affiliated with the U.S. SEC.